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Abstract
Hypertension remains one of the most important preventable contributors to disease and 
death. A direct positive relationship between blood pressure and cardiovascular risk has long 
been recognized. This relationship is strong, continuous, graded, consistent, independent, 
predictive and etiologically signifi cant for those with and without coronary heart disease. It has 
been identifi ed in both men and women, younger and older adults, different racial and ethnic 
groups, different countries and applies to those with high-normal blood pressure as well as 
those with hypertension.
Raised blood pressure is estimated to cause about 7 million premature deaths throughout theworld, 
and 4.5% of the disease burden (64 million disability-adjusted life years (DALYs).It is a major risk 
factor for cerebrovascular disease, coronary heart disease, and cardiac and renalfailure. Treating 
raised blood pressure has been associated with a 35–40% reduction in the riskof stroke and at 
least a 16% reduction in the risk of myocardial infarction. Raised bloodpressure often coexists with 
other cardiovascular risk factors, such as tobacco use, overweight orobesity, dyslipidaemia and 
dysglycaemia, which increase the cardiovascular risk attributable to anylevel of blood pressure. 
Worldwide, these coexisting risk factors are often inadequately addressedin patients with raised 
blood pressure, with the result that, even if their blood pressure is lowered,these people still have 
high cardiovascular morbidity and mortality rates .
Primary prevention of hypertension
Primary prevention includes health promotion and protection involving education in personal 
health and development, proper nutrition, adequate exercise, and a safe living environment  
Primary prevention aims to prevent disease or injury before it ever occurs. This is done by 
preventing exposures to hazards that cause disease or injury, altering unhealthy or unsafe 
behaviours that can lead to disease or injury, and increasing resistance to disease or injury 
should exposure occur.
Hypertension can be prevented by complementary application of strategies that target general 
population and individuals and group at higher risk for high blood pressure. Lifestyle interventions 
are more likely to be successful and the absolute risk reductions in risk of hypertension are 
likely to be greater when targeted in persons who are older and those who have a higher risk of 
developing hypertension compared with their counterparts who are younger and have a lower 
risk. However, prevention strategies applied early in life provide the greatest long-term potential 
for avoiding the precursors that lead to hypertension and elevated blood pressure levels and 
for reducing the overall burden of blood pressure-related complications in community.
A population based approach aimed at achieving a downward shift in the distribution of high 
blood pressure in general population is an important component for any comprehensive plan 
to prevent hypertension. Public health approaches, such as lowering sodium content and 
caloric density in the food supply and providing attractive, safe and convenient opportunities 
for exercise are ideal population-based approaches for reduction of average blood pressure 
in the community.
More intensive targeted approaches, aimed at achieving greater reduction in those who are most 
likely to develop hypertension complement the previously based strategies for prevention of 
hypertension. Groups at high risk of hypertension include those at high normal blood pressure, 
a family history of hypertension, African American black ancestry, overweight or obesity, a 
sedentary life style, excess intake of dietary sodium, insuffi cient intake of potassium, or excess 
consumption of alcohol. 
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Secondary prevention of hypertension
Secondary prevention relies on early detection of disease process and application of interventions 
to prevent progression of disease.Secondary prevention includes screening for disease 
progression and taking preventative measures in order to limit further complications. Secondary 
preventionaims to reduce the impact of a disease or injury that has already occurred. This is 
done by detecting and treating disease or injury as soon as possible to halt or slow its progress, 
encouraging personal strategies to prevent reinjury or recurrence, and implementing programs 
to return people to their original health and function to prevent long-term problems. Abundant 
evidence from randomized controlled trials (RCTs) has shown benefi t of antihypertensive drug 
treatment in reducing important health outcomes in persons with hypertension. 
Despite relatively recent declines in age-adjusted mortality, in 2013, cardiovascular disease 
(CVD) was the primary cause in nearly 801,000 deaths (30.8% of total deaths) in the United 
States.In fact, CVD has been the leading cause of death in the United States for the past 100 
years, except for 1918. Although CVD age-adjusted death rates are reportedly declining in the 
United States, they are increasing in many developing countries, such that CVD is now the 
leading cause of death globally as well
High blood pressure is the most important modifi able risk factor for stroke, accounting for 
more than 50% of the population-attributable fraction for stroke. There is now strong evidence 
from randomized trials that blood pressure-lowering treatment is one of the most effective and 
generalizable strategies for secondary prevention of stroke. Once the patient with stroke has 
stabilized, all patients should receive blood pressure-lowering therapy, irrespective of their 
blood pressure levels. 
Among patients with clinical history of CVD but without hypertension, antihypertensive 
treatment was associated with decreased risk of stroke, CHF, composite CVD events, and all-
cause mortality. Life style and pharmacological therapy made optimal mean blood pressure in 
hypertensive men and women with coronary heart disease. 
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